These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 10839593)

  • 1. Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection. Adult AIDS Clinical Trials Group Study Team 295.
    Fichtenbaum CJ; Zackin R; Rajicic N; Powderly WG; Wheat LJ; Zingman BS
    AIDS; 2000 May; 14(7):845-52. PubMed ID: 10839593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.
    Saag MS; Fessel WJ; Kaufman CA; Merrill KW; Ward DJ; Moskovitz BL; Thomas C; Oleka N; Guarnieri JA; Lee J; Brenner-Gati L; Klausner M
    AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1413-7. PubMed ID: 10555103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients.
    Jandourek A; Vaishampayan JK; Vazquez JA
    AIDS; 1998 Jun; 12(9):1033-7. PubMed ID: 9662200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
    Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
    AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.
    Vazquez JA; Skiest DJ; Nieto L; Northland R; Sanne I; Gogate J; Greaves W; Isaacs R
    Clin Infect Dis; 2006 Apr; 42(8):1179-86. PubMed ID: 16575739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to fluconazole by 23 patients with human immunodeficiency virus infection and oral candidiasis: pharmacological and mycological factors.
    Lacassin F; Damond F; Chochillon C; Longuet P; Lebras J; Vilde JL; Leport C
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1961-3. PubMed ID: 8843316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Itraconazole cyclodextrin solution for fluconazole-refractory oropharyngeal candidiasis in AIDS: correlation of clinical response with in vitro susceptibility.
    Phillips P; Zemcov J; Mahmood W; Montaner JS; Craib K; Clarke AM
    AIDS; 1996 Oct; 10(12):1369-76. PubMed ID: 8902066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of HIV-related fluconazole-resistant oral candidosis with D0870, a new triazole antifungal.
    Cartledge JD; Denning DW; Dupont B; Clumeck N; De Wit S; Midgley J; Hawkins DA; Gazzard BG
    AIDS; 1998 Mar; 12(4):411-6. PubMed ID: 9520171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of fluconazole and itraconazole in the treatment of oral candidiasis in HIV patients.
    Menon T; Umamaheswari K; Kumarasamy N; Solomon S; Thyagarajan SP
    Acta Trop; 2001 Oct; 80(2):151-4. PubMed ID: 11600094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of fluconazole oral suspension and amphotericin B oral suspension in older patients with oropharyngeal candidosis. Multicentre Study Group.
    Taillandier J; Esnault Y; Alemanni M
    Age Ageing; 2000 Mar; 29(2):117-23. PubMed ID: 10791445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of oropharyngeal candidiasis in HIV-infected patients with oral amphotericin B suspension.
    Hood S; Evans J; Bond J; Wilkins E; Denning D
    AIDS Patient Care STDS; 1998 Aug; 12(8):625-7. PubMed ID: 15468434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of sargramostim (rh-GM-CSF) as adjunctive treatment of fluconazole-refractory oropharyngeal candidiasis in patients with AIDS: a pilot study.
    Vazquez JA; Hidalgo JA; De Bono S
    HIV Clin Trials; 2000; 1(3):23-9. PubMed ID: 11590502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refractory mucosal candidiasis in advanced human immunodeficiency virus infection.
    Fichtenbaum CJ; Koletar S; Yiannoutsos C; Holland F; Pottage J; Cohn SE; Walawander A; Frame P; Feinberg J; Saag M; Van der Horst C; Powderly WG
    Clin Infect Dis; 2000 May; 30(5):749-56. PubMed ID: 10816143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40.
    Goldman M; Cloud GA; Wade KD; Reboli AC; Fichtenbaum CJ; Hafner R; Sobel JD; Powderly WG; Patterson TF; Wheat LJ; Stein DK; Dismukes WE; Filler SG; ;
    Clin Infect Dis; 2005 Nov; 41(10):1473-80. PubMed ID: 16231260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis.
    Barchiesi F; Arzeni D; Del Prete MS; Sinicco A; Falconi Di Francesco L; Pasticci MB; Lamura L; Nuzzo MM; Burzacchini F; Coppola S; Chiodo F; Scalise G
    J Antimicrob Chemother; 1998 May; 41(5):541-8. PubMed ID: 9630407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluconazole resistant oral candidiasis in HIV-infected patients.
    Tumbarello M; Tacconelli E; Caldarola G; Morace G; Cauda R; Ortona L
    Oral Dis; 1997 May; 3 Suppl 1():S110-2. PubMed ID: 9456668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative growth measurement of Candida species in a single concentration of fluconazole predicts the clinical response to fluconazole in HIV infected patients with oral candidosis.
    Cartledge JD; Midgley J; Gazzard BG
    J Antimicrob Chemother; 1996 Feb; 37(2):275-83. PubMed ID: 8707737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic options for the management of oropharyngeal and esophageal candidiasis in HIV/AIDS patients.
    Vazquez JA
    HIV Clin Trials; 2000; 1(1):47-59. PubMed ID: 11590489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Itraconazole suspension in the treatment of HIV-infected patients with fluconazole-resistant oropharyngeal candidiasis and esophagitis].
    Eichel M; Just-Nübling G; Helm EB; Stille W
    Mycoses; 1996; 39 Suppl 1():102-6. PubMed ID: 8767280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study of fluconazole suspension for the treatment of oesophageal candidiasis in patients with AIDS.
    Laine L; Rabeneck L
    Aliment Pharmacol Ther; 1995 Oct; 9(5):553-6. PubMed ID: 8580277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.